6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis
ConditionOsteoarthritis, Hip
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAptissen SA
About this trial
Multicenter, independent study of Synolis VA 80/160 over a period of 6 months
Eligibility criteria
Qualifiers
Patient over 18 years of age,
Treated hip pain: Oxford score ≥ 21/60,
Kellgren-Lawrence positive X-ray stage: II - III (inclusion radiograph dated no more than 6 months before the inclusion visit),
Symptoms related to osteoarthritis of the hip for at least 2 months,
Disqualifiers
Pregnancy,
Participation in another clinical trial,
Skin lesion near the injection site,
Recent or old infection of the affected joint,
Trial design
Treatments tested in this trial
- SYNOLIS VA 80/160
Treatment groups
70 Participants
are divided into 1 treatment groupLocations
3Service de Rhumatologie, Hôpital Nord Franche-Comté Belfort France
Service de chirurgie orthopédique et traumatologie Centre Hospitalier de Dunkerque CHD Dunkirk France
Service d'Orthopédie II (Membre Inférieur, Chirurgie du Sport et Chirurgie Septique) Hôpital Salengro, CHRU de Lille Lille France
Sponsors and collaborators
Aptissen SA
Lead sponsor
Source ClinicalTrials.gov